Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1975-09-11
1977-06-21
Myers, Jane S.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424308, 424309, 424312, 2604045, 260471A, 260476R, 260479R, C07C 6916, C07C 6928, A61K 3122, A61K 3123
Patent
active
040312429
ABSTRACT:
This invention covers diacylated derivatives of .gamma.-glutamyl dopamine selected from the group consisting of ##STR1## where R is a C.sub.1 -C.sub.12 straight or branched chain alkyl radical, a phenyl ring or a substituted phenyl ring and R' is H or a C.sub.1 -C.sub.7 alkyl, and a pharmaceutically acceptable acid addition salt thereof.
The compounds of this invention are useful to increase the renal blood flow by being administered to warm-blooded animals by clinically accepted routes of administration such as oral, parenteral, rectal and the like.
REFERENCES:
patent: 3891696 (1975-06-01), Bodor et al.
patent: 3903147 (1975-09-01), Kyncl et al.
Jones Peter Hadley
Kyncl Jaroslav
Ours Carroll Wayne
Abbott Laboratories
Mallare Vincent A.
Myers Jane S.
Niblack Robert L.
LandOfFree
Diacylated derivatives of .gamma.-glutamyl dopamine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diacylated derivatives of .gamma.-glutamyl dopamine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diacylated derivatives of .gamma.-glutamyl dopamine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-737030